DelveInsight’s Glioma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Glioma for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Glioma forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Glioma till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Glioma market.
• Identifying patient populations in the global Glioma market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Glioma therapeutics in each of the markets covered.
• To understand the future market competition in the global Glioma therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Glioma for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
Note: This report requires 7-10 business days to complete.
'
Table of Contents
• Glioma overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Glioma Market
• Global Epidemiology of Glioma Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Glioma Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Glioma (2013-2023)
• Table 7: Glioma Global Market (USD Millions), (2013-2015)
• Table 8: Glioma Global Market (USD Millions), (2016-2023)
• Table 9: Glioma US Market (USD Millions), (2013-2015)
• Table 10: Glioma US Market (USD Millions), (2016-2023)
• Table 11: Glioma Germany Market (USD Millions), (2013-2015)
• Table 12: Glioma Germany Market (USD Millions), (2016-2023)
• Table 13: Glioma United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Glioma United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Glioma France Market (USD Millions), (2013-2015)
• Table 16: Glioma France Market (USD Millions), (2016-2023)
• Table 17: Glioma Italy Market (USD Millions), (2013-2015)
• Table 18: Glioma Italy Market (USD Millions), (2016-2023)
• Table 19: Glioma Spain Market (USD Millions), (2013-2015)
• Table 20: Glioma Spain Market (USD Millions), (2016-2023)
• Table 21: Glioma Japan Market (USD Millions), (2013-2015)
• Table 22: Glioma Japan Market (USD Millions), (2016-2023)
• Table 23: Glioma ROW Market (USD Millions), (2013-2015)
• Table 24: Glioma ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Glioma Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Glioma (2013-2023)
• Figure 3: Glioma Global Market (USD Millions), (2013-2015)
• Figure 4: Glioma Global Market (USD Millions), (2016-2023)
• Figure 5: Glioma US Market (USD Millions), (2013-2015)
• Figure 6: Glioma US Market (USD Millions), (2016-2023)
• Figure 7: Glioma Germany Market (USD Millions), (2013-2015)
• Figure 8: Glioma Germany Market (USD Millions), (2016-2023)
• Figure 9: Glioma United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Glioma United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Glioma France Market (USD Millions), (2013-2015)
• Figure 12: Glioma France Market (USD Millions), (2016-2023)
• Figure 13: Glioma Italy Market (USD Millions), (2013-2015)
• Figure 14: Glioma Italy Market (USD Millions), (2016-2023)
• Figure 15: Glioma Spain Market (USD Millions), (2013-2015)
• Figure 16: Glioma Spain Market (USD Millions), (2016-2023)
• Figure 17: Glioma Japan Market (USD Millions), (2013-2015)
• Figure 18: Glioma Japan Market (USD Millions), (2015-2023)
• Figure 19: Glioma ROW Market (USD Millions), (2013-2015)
• Figure 20: Glioma ROW Market (USD Millions), (2016-2023)
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Tocagen Inc.
• Sanofi
• Pfizer Inc.
• Merck & Co. Inc.
• Eli Lilly and Company
• Eisai Co. Ltd.
• C. H. Boehringer Sohn AG & Co. KG
• Bayer AG
